Zenlabs Ethica, a company in the Diversified Commercial Services industry, reported revenue of ₹11 crore and a net loss of ₹0.09 crore for the September 2026 quarter.
Zenlabs Ethica (BSE: ZENLABS) closed at ₹28.00 on 20 Nov 2026, down 8.2% over the past year. Its market capitalisation is ₹18 crore.
Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.